Main > ONCOLOGY (**) > Skin Cancer>Melanoma>MET>BRAF+*** > Treatment > USA. P. Binimetinib+Encorafenib

---

USA. P. Binimetinib+Encorafenib's subsections
(*) EU Approval Date: 2018. 09.20.
(*) USA Approval Date: 2018. 06.27.
Company
Patent>Assignee; Claims; No.; Etc.
Patent>FDA Orange Book Only
Patent>Total USA No.: 18
Patent>UpDate: 2018. 12.11.
TradeMark
TradeMark Web-Site

USA. P. Binimetinib+Encorafenib's products
This section has no products